AtriCure, Inc. (ATRC)
28.81
+0.01
(+0.03%)
USD |
NASDAQ |
May 20, 10:21
AtriCure Research and Development Expense (Quarterly) : 23.50M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Intuitive Surgical, Inc. | 361.60M |
| STRATA Skin Sciences, Inc. | 0.067M |
| Insulet Corp. | 89.70M |
| QuidelOrtho Corp. | 44.90M |
| Abbott Laboratories | 767.00M |